House committee questions McKinsey executive over opioid, FDA consulting work

Members of Congress questioned global consulting firm McKinsey & Company's top managing partner Wednesday about the company's work for U.S. health regulators as it advised opioid drugmakers on how to boost painkiller sales. The hearing is part of an ongoing investigation into McKinsey's role in the opioid crisis.